Clik here to view.
venBio Comments on its Recent Nomination of Four Highly-Qualified Candidates...
Tuesday, November 22nd 2016 at 2:00pm UTC Lack of Independent Board Oversight Has Contributed to Company’s Numerous Strategic Missteps, in venBio’s View Believes New, Independent Leadership is Needed...
View ArticleClik here to view.
Taro Announces Appointment of New CEO and New Board Member Nominations
Tuesday, November 22nd 2016 at 1:30pm UTC HAWTHORNE, N.Y.–(BUSINESS WIRE)– Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today the appointment of Mr. Uday...
View ArticleClik here to view.
Nanotherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference
Tuesday, November 22nd 2016 at 5:11pm UTC ALACHUA, Fla.–(BUSINESS WIRE)– Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that management will give...
View ArticleClik here to view.
Surmodics to Attend Piper Jaffray Healthcare Conference
Tuesday, November 22nd 2016 at 1:05pm UTC Webcast is Live on Tuesday, November 29, at 11:30 a.m. (ET) EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical...
View ArticleClik here to view.
Axcella to Present at the 28th Annual Piper Jaffray Healthcare Conference
Tuesday, November 22nd 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Axcella, a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino...
View ArticleClik here to view.
Ignyta to Present at 28th Annual Piper Jaffray Healthcare Conference
Tuesday, November 22nd 2016 at 12:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko,...
View ArticleClik here to view.
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016
Tuesday, November 22nd 2016 at 10:00pm UTC – UCART19 Phase 1 trial on-going – Successful cGMP Manufacturing for UCART123 – Strong cash position of $295 million1 as of September 30, 2016 – Additional...
View ArticleClik here to view.
Newron Pharmaceuticals to Participate in the Piper Jaffray 28th Annual...
Tuesday, November 22nd 2016 at 9:05pm UTC MILAN–(BUSINESS WIRE)– Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for...
View ArticleClik here to view.
Mersana Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare...
Wednesday, November 23rd 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Mersana Therapeutics, Inc., today announced that Anna Protopapas, President and Chief Executive Officer, will present at...
View ArticleClik here to view.
Bard to Present at the Piper Jaffray Healthcare Conference
Wednesday, November 23rd 2016 at 3:30pm UTC MURRAY HILL, N.J.–(BUSINESS WIRE)– C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Piper Jaffray Healthcare Conference in New York...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part at the Citi 2016 Global Healthcare Conference
Wednesday, November 30th 2016 at 2:54pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Citi 2016 Global Healthcare Conference on Wednesday, December 7,...
View ArticleClik here to view.
Tyto Care and American Well to Bring Physical Examination to Telehealth Visits
Wednesday, November 30th 2016 at 1:00pm UTC New partnership enables virtual visits with remote examinations, greatly expanding the boundaries of telehealth NEW YORK–(BUSINESS WIRE)– Tyto Care, a...
View ArticleClik here to view.
Pfizer Announces Positive Top-Line Results from the Pivotal Comparative...
Wednesday, November 30th 2016 at 1:30pm UTC Results Demonstrate Equivalence in Objective Response Rate in Patients with HER2-positive Metastatic Breast Cancer NEW YORK–(BUSINESS WIRE)– Pfizer Inc....
View ArticleClik here to view.
David Epstein Joins as Special Advisor to Remedy Pharmaceuticals
Wednesday, November 30th 2016 at 2:30pm UTC Former Head of Novartis’ Pharmaceuticals Division to help guide future of company focused on groundbreaking therapy for CNS-related edema NEW YORK–(BUSINESS...
View ArticleClik here to view.
Veeva to Present at Upcoming Investor Conferences
Wednesday, November 30th 2016 at 11:43pm UTC PLEASANTON, Calif.–(BUSINESS WIRE)– Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced...
View ArticleClik here to view.
Aerie Pharmaceuticals to Participate in Two Investor Conferences in December
Thursday, December 1st 2016 at 12:30pm UTC IRVINE, Calif.–(BUSINESS WIRE)– Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and...
View ArticleClik here to view.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at...
Thursday, December 1st 2016 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President,...
View ArticleClik here to view.
Taro Announces Appointment of Interim CEO
Thursday, December 1st 2016 at 10:05pm UTC HAWTHORNE, N.Y.–(BUSINESS WIRE)– Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that its Board of Directors has...
View ArticleClik here to view.
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2017 Results...
Thursday, December 1st 2016 at 8:39pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2017 first quarter results, Friday, December 9, 2016,...
View ArticleClik here to view.
LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint
Thursday, December 1st 2016 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced today positive top-line results of a study that evaluated the use of LYRICA® (pregabalin) Capsules...
View Article